Ronald Craig  Janish net worth and biography

Ronald Janish Biography and Net Worth

EVP of Perrigo
Ronald Janish was named Executive Vice President of Global Operations and Supply Chain in October of 2015.  He served as Senior Vice President of International and RX Operations from 2012 until 2015 and as Managing Director of Perrigo’s Australian operations from 2010 to 2012.  Previously he held Senior Vice President roles for Perrigo in International Market Development, China Business Development and Global Procurement. Prior to joining Perrigo in 2003, Mr. Janish held multiple senior level roles in global procurement for Nalco Chemicals and GE Plastics.

What is Ronald Craig Janish's net worth?

The estimated net worth of Ronald Craig Janish is at least $649,948.29 as of March 8th, 2023. Mr. Janish owns 20,191 shares of Perrigo stock worth more than $649,948 as of March 29th. This net worth approximation does not reflect any other assets that Mr. Janish may own. Learn More about Ronald Craig Janish's net worth.

How old is Ronald Craig Janish?

Mr. Janish is currently 58 years old. There are 5 older executives and no younger executives at Perrigo. The oldest executive at Perrigo is Mr. Thomas M. Farrington, Chief Information Officer & Executive VP, who is 67 years old. Learn More on Ronald Craig Janish's age.

How do I contact Ronald Craig Janish?

The corporate mailing address for Mr. Janish and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Ronald Craig Janish's contact information.

Has Ronald Craig Janish been buying or selling shares of Perrigo?

Ronald Craig Janish has not been actively trading shares of Perrigo during the last ninety days. Most recently, Ronald Craig Janish sold 4,500 shares of the business's stock in a transaction on Wednesday, March 8th. The shares were sold at an average price of $36.92, for a transaction totalling $166,140.00. Following the completion of the sale, the executive vice president now directly owns 20,191 shares of the company's stock, valued at $745,451.72. Learn More on Ronald Craig Janish's trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (CEO), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 9 times. They purchased a total of 54,480 shares worth more than $1,599,465.50. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 197,646 shares worth more than $7,065,844.50. The most recent insider tranaction occured on March, 5th when EVP Alison Ives bought 2,490 shares worth more than $67,877.40. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 3/5/2024.

Ronald Craig Janish Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2023Sell4,500$36.92$166,140.0020,191View SEC Filing Icon  
3/7/2022Sell3,954$36.73$145,230.42View SEC Filing Icon  
11/8/2019Sell2,424$49.90$120,957.606,006View SEC Filing Icon  
See Full Table

Ronald Craig Janish Buying and Selling Activity at Perrigo

This chart shows Ronald Craig Janish's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $32.19
Low: $31.48
High: $32.35

50 Day Range

MA: $31.11
Low: $26.22
High: $33.64

2 Week Range

Now: $32.19
Low: $25.77
High: $40.28

Volume

1,583,319 shs

Average Volume

2,734,551 shs

Market Capitalization

$4.36 billion

P/E Ratio

N/A

Dividend Yield

3.51%

Beta

0.61